Search Results - "HAMAJI, M"

Refine Results
  1. 1

    CD26/DPP4 Inhibitor: A Novel Prophylactic Drug for Chronic Allograft Dysfunction after Clinical Lung Transplantation by Yamada, Y., Nishikawa, S., Tanaka, S., Hamaji, M., Nakajima, D., Ohsumi, A., Chen-Yoshikawa, T.F., Date, H.

    “…Prevention of chronic lung allograft dysfunction (CLAD) is still an issue. In mouse/rat lung transplantation (LTx) models, we have shown the efficacy of…”
    Get full text
    Journal Article
  2. 2

    Clinicopathological features of cytokeratin 5‐positive pulmonary adenocarcinoma by Terada, K, Yoshizawa, A, Sumiyoshi, S, Rokutan‐Kurata, M, Nakajima, N, Hamaji, M, Sonobe, M, Menju, T, Date, H, Haga, H

    Published in Histopathology (01-02-2023)
    “…Cytokeratin 5 (CK5) is a marker for pulmonary squamous cell carcinoma; however, CK5 is sometimes present in pulmonary adenocarcinoma (ADC), and there is…”
    Get full text
    Journal Article
  3. 3

    Post-Transplant Outcomes of Novel Surgical Procedures to Deal with Graft Size Mismatch in Living-Donor Lobar Lung Transplantation by Nakajima, D., Yutaka, Y., Hamaji, M., Tanaka, S., Yamada, Y., Ohsumi, A., Date, H.

    “…Various living-donor lobar lung transplant (LDLLT) procedures have been developed in order to resolve the serious issue of graft size mismatch. The purpose of…”
    Get full text
    Journal Article
  4. 4

    Strategies for refinement of occupational inhalation exposure evaluation in the EPA TSCA risk evaluation process by Lynch, Heather N., Allen, Laura H., Hamaji, Claire M., Maier, Andrew

    Published in Toxicology and Industrial Health (01-03-2023)
    “…The focus on occupational exposures in the first published risk evaluations of existing chemicals by the Environmental Protection Agency (EPA) under the…”
    Get full text
    Book Review Journal Article
  5. 5
  6. 6

    Native Lung Complications after Living-Donor Lobar Lung Transplantation by Mineura, K., Chen-Yoshikawa, T.F., Tanaka, S., Yamada, Y., Yutaka, Y., Nakajima, D., Ohsumi, A., Hamaji, M., Date, H.

    “…Given the severe donor shortage in Japan, living-donor lobar lung transplantation (LDLLT) is a viable option for critically ill patients. Furthermore, native…”
    Get full text
    Journal Article
  7. 7

    Analysis of the Change in Sleep Quality in Lung Transplant Recipients by Tokuno, J., Oga, T., Chen-Yoshikawa, T.F., Oto, T., Okawa, T., Okada, Y., Akiba, M., Ikeda, M., Tanaka, S., Yamada, Y., Yutaka, Y., Ohsumi, A., Nakajima, D., Hamaji, M., Isomi, M., Chin, K., Date, H.

    “…We previously reported that sleep quality is impaired in waitlisted patients for lung transplantation in Japan, and that respiratory symptoms and psychological…”
    Get full text
    Journal Article
  8. 8

    Protective Effects of Necrosulfonamide on Ischemia-Reperfusion Injury in Rat Lung by Ueda, S., Chen-Yoshikawa, T.F., Mineura, K., Yamanashi, K., Oda, H., Yokoyama, Y., Ikeda, M., Tokuno, J., Kayawake, H., Yamagishi, H., Gochi, F., Okabe, R., Tanaka, S., Yamada, Y., Nakajima, D., Ohsumi, A., Hamaji, M., Date, H.

    “…In lung transplantation, ischemia-reperfusion injury (IRI) plays a critical role in the development of primary graft dysfunction. Among cell deaths induced by…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Development of a composite and vascularized tracheal scaffold in the omentum for in situ tissue engineering: a canine model by Hamaji, Masatsugu, Kojima, Fumitsugu, Koyasu, Sho, Tsuruyama, Tatsuaki, Komatsu, Teruya, Ikuno, Tsuyoshi, Date, Hiroshi, Nakamura, Tatsuo

    “…OBJECTIVES We herein report on development of a composite (synthetic and biological) tracheal scaffold with vascularized autologous connective tissue in the…”
    Get full text
    Journal Article